Cardiovascular effects of romifidine in dogs

Bruno H Pypendop, John P. Verstegen

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective - To characterize the cardiovascular effects of romifidine at doses ranging from 5 to 100 μg/kg of body weight, IV. Animals - 25 clinically normal male Beagles. Procedure - Romifidine was administered IV at a dose of 5, 10, 25, 50, or 100 μg/kg (n = 5/group). Heart rate, arterial pressure, central venous pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, body temperature, cardiac output, and PCV were measured immediately prior to and at selected times after romifidine administration. Cardiac index, stroke index, rate-pressure product, systemic and pulmonary vascular resistance indices, and left and right ventricular stroke work indices were calculated. Degree of sedation was assessed by an observer who was blinded to the dose administered. Results - Romifidine induced a decrease in heart rate, pulmonary arterial pressure, rate-pressure product, cardiac index, and right ventricular stroke work index and an increase in central venous pressure, pulmonary capillary wedge pressure, and systemic vascular resistance index. In dogs given romifidine at a dose of 25, 50, or 100 μg/kg, an initial increase followed by a prolonged decrease in arterial pressure was observed. Arterial pressure immediately decreased in dogs given romifidine at a dose of 5 or 10 μg/kg. Conclusions and Clinical Relevance - Results suggest that IV administration of romifidine induces dose-dependent cardiovascular changes in dogs. However, the 2 lowest doses (5 and 10 μg/kg) induced less cardiovascular depression, and doses ≥ 25 μg/kg induced similar cardiovascular changes, suggesting that there may be a ceiling on the cardiovascular effects of romifidine.

Original languageEnglish (US)
Pages (from-to)490-495
Number of pages6
JournalAmerican Journal of Veterinary Research
Volume62
Issue number4
StatePublished - Apr 2001

Fingerprint

Dogs
dogs
Arterial Pressure
Vascular Resistance
lungs
dosage
Central Venous Pressure
Pulmonary Wedge Pressure
Stroke
stroke
Heart Rate
blood vessels
Pressure
heart rate
Lung
romifidine
Body Temperature
Cardiac Output
administered dose
sedation

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Cardiovascular effects of romifidine in dogs. / Pypendop, Bruno H; Verstegen, John P.

In: American Journal of Veterinary Research, Vol. 62, No. 4, 04.2001, p. 490-495.

Research output: Contribution to journalArticle

Pypendop, Bruno H ; Verstegen, John P. / Cardiovascular effects of romifidine in dogs. In: American Journal of Veterinary Research. 2001 ; Vol. 62, No. 4. pp. 490-495.
@article{f46297b71a0b43c48e43033b77b76ef2,
title = "Cardiovascular effects of romifidine in dogs",
abstract = "Objective - To characterize the cardiovascular effects of romifidine at doses ranging from 5 to 100 μg/kg of body weight, IV. Animals - 25 clinically normal male Beagles. Procedure - Romifidine was administered IV at a dose of 5, 10, 25, 50, or 100 μg/kg (n = 5/group). Heart rate, arterial pressure, central venous pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, body temperature, cardiac output, and PCV were measured immediately prior to and at selected times after romifidine administration. Cardiac index, stroke index, rate-pressure product, systemic and pulmonary vascular resistance indices, and left and right ventricular stroke work indices were calculated. Degree of sedation was assessed by an observer who was blinded to the dose administered. Results - Romifidine induced a decrease in heart rate, pulmonary arterial pressure, rate-pressure product, cardiac index, and right ventricular stroke work index and an increase in central venous pressure, pulmonary capillary wedge pressure, and systemic vascular resistance index. In dogs given romifidine at a dose of 25, 50, or 100 μg/kg, an initial increase followed by a prolonged decrease in arterial pressure was observed. Arterial pressure immediately decreased in dogs given romifidine at a dose of 5 or 10 μg/kg. Conclusions and Clinical Relevance - Results suggest that IV administration of romifidine induces dose-dependent cardiovascular changes in dogs. However, the 2 lowest doses (5 and 10 μg/kg) induced less cardiovascular depression, and doses ≥ 25 μg/kg induced similar cardiovascular changes, suggesting that there may be a ceiling on the cardiovascular effects of romifidine.",
author = "Pypendop, {Bruno H} and Verstegen, {John P.}",
year = "2001",
month = "4",
language = "English (US)",
volume = "62",
pages = "490--495",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "4",

}

TY - JOUR

T1 - Cardiovascular effects of romifidine in dogs

AU - Pypendop, Bruno H

AU - Verstegen, John P.

PY - 2001/4

Y1 - 2001/4

N2 - Objective - To characterize the cardiovascular effects of romifidine at doses ranging from 5 to 100 μg/kg of body weight, IV. Animals - 25 clinically normal male Beagles. Procedure - Romifidine was administered IV at a dose of 5, 10, 25, 50, or 100 μg/kg (n = 5/group). Heart rate, arterial pressure, central venous pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, body temperature, cardiac output, and PCV were measured immediately prior to and at selected times after romifidine administration. Cardiac index, stroke index, rate-pressure product, systemic and pulmonary vascular resistance indices, and left and right ventricular stroke work indices were calculated. Degree of sedation was assessed by an observer who was blinded to the dose administered. Results - Romifidine induced a decrease in heart rate, pulmonary arterial pressure, rate-pressure product, cardiac index, and right ventricular stroke work index and an increase in central venous pressure, pulmonary capillary wedge pressure, and systemic vascular resistance index. In dogs given romifidine at a dose of 25, 50, or 100 μg/kg, an initial increase followed by a prolonged decrease in arterial pressure was observed. Arterial pressure immediately decreased in dogs given romifidine at a dose of 5 or 10 μg/kg. Conclusions and Clinical Relevance - Results suggest that IV administration of romifidine induces dose-dependent cardiovascular changes in dogs. However, the 2 lowest doses (5 and 10 μg/kg) induced less cardiovascular depression, and doses ≥ 25 μg/kg induced similar cardiovascular changes, suggesting that there may be a ceiling on the cardiovascular effects of romifidine.

AB - Objective - To characterize the cardiovascular effects of romifidine at doses ranging from 5 to 100 μg/kg of body weight, IV. Animals - 25 clinically normal male Beagles. Procedure - Romifidine was administered IV at a dose of 5, 10, 25, 50, or 100 μg/kg (n = 5/group). Heart rate, arterial pressure, central venous pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, body temperature, cardiac output, and PCV were measured immediately prior to and at selected times after romifidine administration. Cardiac index, stroke index, rate-pressure product, systemic and pulmonary vascular resistance indices, and left and right ventricular stroke work indices were calculated. Degree of sedation was assessed by an observer who was blinded to the dose administered. Results - Romifidine induced a decrease in heart rate, pulmonary arterial pressure, rate-pressure product, cardiac index, and right ventricular stroke work index and an increase in central venous pressure, pulmonary capillary wedge pressure, and systemic vascular resistance index. In dogs given romifidine at a dose of 25, 50, or 100 μg/kg, an initial increase followed by a prolonged decrease in arterial pressure was observed. Arterial pressure immediately decreased in dogs given romifidine at a dose of 5 or 10 μg/kg. Conclusions and Clinical Relevance - Results suggest that IV administration of romifidine induces dose-dependent cardiovascular changes in dogs. However, the 2 lowest doses (5 and 10 μg/kg) induced less cardiovascular depression, and doses ≥ 25 μg/kg induced similar cardiovascular changes, suggesting that there may be a ceiling on the cardiovascular effects of romifidine.

UR - http://www.scopus.com/inward/record.url?scp=0035079794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035079794&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 490

EP - 495

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 4

ER -